找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION 2024/2025影响因子:2.506 (J AM PHARM ASSOC) (1544-3191). (PHARMACOLOGY  ...234
Total Citations:4062; 2023 JIF:2.506; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:2.315; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.8; Immediacy Index-dealt:0.861; 2023 JCI:0.61; JCI Rank: 199/354 ; Total Articles:187; JCI Quartile:Q3; JCI Percentile:43.93; Eigenfactor:0.004; Normalized Eigenfactor:0.957; Article Influence Score:0.609; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:208; % of Articles in Citable items:0.899; Cited Half-Life:5.6; Citing Half-Life:6.7; % of OA Gold:0.1075; Publisher name:TAYLOR & FRANCIS INC; Publisher address:530 WALNUT STREET, STE 850, PHILAD
投票 SCIE期刊Drug Design Development and Therapy 2024/2025影响因子:4.741 (DRUG DES DEV THER) (1177-8881). (PHARMACOLOGY & PHARMACY  ...234
Total Citations:14189; 2023 JIF:4.741; JIFRank: 55/354 ; Rank-JIF: 55; Number-of-JIF:354; 5 Year JIF:4.836; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.6; Immediacy Index:0.8; Immediacy Index-dealt:0.818; 2023 JCI:1.1; JCI Rank: 68/354 ; Total Articles:205; JCI Quartile:Q1; JCI Percentile:80.93; Eigenfactor:0.013; Normalized Eigenfactor:2.91; Article Influence Score:0.856; JIF Percentile:84.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:256; % of Articles in Citable items:0.8008; Cited Half-Life:4.8; Citing Half-Life:5.7; % of OA Gold:0.975; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, M
投票 SCIE期刊JOURNAL OF CHEMOTHERAPY 2024/2025影响因子:1.981 (J CHEMOTHERAPY) (1120-009X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scienc  ...234
Total Citations:1813; 2023 JIF:1.981; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:2.127; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.3; Immediacy Index-dealt:0.313; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:56; JCI Quartile:Q3; JCI Percentile:35.56; Eigenfactor:0.001; Normalized Eigenfactor:0.246; Article Influence Score:0.419; JIF Percentile:27.5; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:69; % of Articles in Citable items:0.8116; Cited Half-Life:8.9; Citing Half-Life:5.4; % of OA Gold:0.0491; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LAN
投票 SCIE期刊CURRENT MEDICINAL CHEMISTRY 2024/2025影响因子:3.535 (CURR MED CHEM) (0929-8673). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sci  ...234
Total Citations:20286; 2023 JIF:3.535; JIFRank: 100/354 ; Rank-JIF: 100; Number-of-JIF:354; 5 Year JIF:4.185; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.5; Immediacy Index:2.1; Immediacy Index-dealt:2.133; 2023 JCI:0.58; JCI Rank: 207/354 ; Total Articles:42; JCI Quartile:Q3; JCI Percentile:34.03; Eigenfactor:0.01; Normalized Eigenfactor:2.254; Article Influence Score:0.708; JIF Percentile:56.3; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:242; % of Articles in Citable items:0.1736; Cited Half-Life:9.1; Citing Half-Life:7.6; % of OA Gold:0.0031; Publisher name:C M B ASSOC; Publisher address:34 BOULEVARD SOLFERINO, POITIERS, FRANCE,
投票 SCIE期刊CARDIOVASCULAR DRUGS AND THERAPY 2024/2025影响因子:3.146 (CARDIOVASC DRUG THER) (0920-3206). (PHARMACOLOGY & PHARMACY  ...234
Total Citations:3282; 2023 JIF:3.146; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.393; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.5; Immediacy Index-dealt:0.524; 2023 JCI:0.8; JCI Rank: 125/354 ; Total Articles:74; JCI Quartile:Q2; JCI Percentile:64.83; Eigenfactor:0.004; Normalized Eigenfactor:0.822; Article Influence Score:0.823; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:101; % of Articles in Citable items:0.7327; Cited Half-Life:4.9; Citing Half-Life:5.8; % of OA Gold:0.2652; Publisher name:SPRINGER SINGAPORE PTE LTD; Publisher address:152 Beach Road, #21-01 Gateway
投票 SCIE期刊PHARMACOGENOMICS JOURNAL 2024/2025影响因子:2.943 (PHARMACOGENOMICS J) (1470-269X). (PHARMACOLOGY & PHARMACY)(药理学与药学)S  ...234
Total Citations:2417; 2023 JIF:2.943; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:2.601; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.9; Immediacy Index:0.6; Immediacy Index-dealt:0.648; 2023 JCI:0.74; JCI Rank: 149/354 ; Total Articles:19; JCI Quartile:Q2; JCI Percentile:58.05; Eigenfactor:0.002; Normalized Eigenfactor:0.427; Article Influence Score:0.678; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:21; % of Articles in Citable items:0.9048; Cited Half-Life:7.8; Citing Half-Life:8.7; % of OA Gold:0.2973; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Unit
投票 SCIE期刊Current Molecular Pharmacology 2024/2025影响因子:2.425 (CURR MOL PHARMACOL) (1874-4672). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:1318; 2023 JIF:2.425; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.883; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.4; Immediacy Index:1.2; Immediacy Index-dealt:1.223; 2023 JCI:0.52; JCI Rank: 227/354 ; Total Articles:36; JCI Quartile:Q3; JCI Percentile:36.02; Eigenfactor:0.001; Normalized Eigenfactor:0.24; Article Influence Score:0.513; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:70; % of Articles in Citable items:0.5143; Cited Half-Life:4.6; Citing Half-Life:8.7; % of OA Gold:0.0043; Publisher name:ACADEMIC PRESS INC ELSEVIER SCIENCE; Publisher address:525 B ST, STE 1900, SAN
投票 SCIE期刊Journal of Natural Medicines 2024/2025影响因子:2.513 (J NAT MED-TOKYO) (1340-3443). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:3302; 2023 JIF:2.513; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:3.139; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.2; Immediacy Index:0.4; Immediacy Index-dealt:0.474; 2023 JCI:0.77; JCI Rank: 135/354 ; Total Articles:81; JCI Quartile:Q2; JCI Percentile:62.01; Eigenfactor:0.002; Normalized Eigenfactor:0.416; Article Influence Score:0.446; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:89; % of Articles in Citable items:0.9101; Cited Half-Life:6.4; Citing Half-Life:8.6; % of OA Gold:0.1583; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Unit
投票 SCIE期刊Biomedicines 2024/2025影响因子:3.918 (BIOMEDICINES) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index E  ...234
Total Citations:28411; 2023 JIF:3.918; JIFRank: 85/354 ; Rank-JIF: 85; Number-of-JIF:354; 5 Year JIF:4.171; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.7; Immediacy Index:1; Immediacy Index-dealt:1.131; 2023 JCI:0.88; JCI Rank: 105/354 ; Total Articles:2262; JCI Quartile:Q2; JCI Percentile:69.05; Eigenfactor:0.04; Normalized Eigenfactor:8.786; Article Influence Score:0.808; JIF Percentile:66.4; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:3294; % of Articles in Citable items:0.6867; Cited Half-Life:2; Citing Half-Life:6.9; % of OA Gold:0.9965; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDO
投票 SCIE期刊EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY 2024/2025影响因子:2.483 (EXP CLIN PSYCHOPHARM) (1064-1297). (PHARMACOLOG  ...234
Total Citations:3004; 2023 JIF:2.483; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.474; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.2; Immediacy Index:0.3; Immediacy Index-dealt:0.372; 2023 JCI:0.78; JCI Rank: 133/354 ; Total Articles:60; JCI Quartile:Q2; JCI Percentile:59.6; Eigenfactor:0.003; Normalized Eigenfactor:0.66; Article Influence Score:0.821; JIF Percentile:54.5; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:64; % of Articles in Citable items:0.9375; Cited Half-Life:8.7; Citing Half-Life:7.7; % of OA Gold:0.181; Publisher name:UNIV CATOLICA SAN ANTONIO, FAC CENCIAS SALUD ACTIVIDAD FISICA & DEPORTE; Publi
投票 SCIE期刊JOURNAL OF PHARMACEUTICAL SCIENCES 2024/2025影响因子:3.706 (J PHARM SCI-US) (0022-3549). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:26522; 2023 JIF:3.706; JIFRank: 90/354 ; Rank-JIF: 90; Number-of-JIF:354; 5 Year JIF:3.525; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:1.4; Immediacy Index-dealt:1.465; 2023 JCI:0.87; JCI Rank: 109/354 ; Total Articles:271; JCI Quartile:Q2; JCI Percentile:70.35; Eigenfactor:0.009; Normalized Eigenfactor:2.008; Article Influence Score:0.597; JIF Percentile:63.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:297; % of Articles in Citable items:0.9125; Cited Half-Life:11.6; Citing Half-Life:8.6; % of OA Gold:0.1743; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊DRUG DEVELOPMENT RESEARCH 2024/2025影响因子:3.573 (DRUG DEVELOP RES) (0272-4391). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sc  ...234
Total Citations:3188; 2023 JIF:3.573; JIFRank: 100/354 ; Rank-JIF: 100; Number-of-JIF:354; 5 Year JIF:4.120; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.5; Immediacy Index:1.1; Immediacy Index-dealt:1.135; 2023 JCI:0.95; JCI Rank: 92/354 ; Total Articles:86; JCI Quartile:Q2; JCI Percentile:74.15; Eigenfactor:0.003; Normalized Eigenfactor:0.571; Article Influence Score:0.64; JIF Percentile:71.9; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:109; % of Articles in Citable items:0.789; Cited Half-Life:4.3; Citing Half-Life:6.6; % of OA Gold:0.0663; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBR
投票 SCIE期刊LIFE SCIENCES 2024/2025影响因子:5.259 (LIFE SCI) (0024-3205). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index  ...234
Total Citations:43620; 2023 JIF:5.259; JIFRank: 40/354 ; Rank-JIF: 40; Number-of-JIF:354; 5 Year JIF:5.336; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.1; Immediacy Index:1.1; Immediacy Index-dealt:1.142; 2023 JCI:1.4; JCI Rank: 34/354 ; Total Articles:645; JCI Quartile:Q1; JCI Percentile:90.54; Eigenfactor:0.04; Normalized Eigenfactor:8.687; Article Influence Score:0.963; JIF Percentile:88.8; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:776; % of Articles in Citable items:0.8312; Cited Half-Life:4.4; Citing Half-Life:6.7; % of OA Gold:0.1209; Publisher name:UNIV NACL CENTRO PROVINCIA BUENOS AIRES (UNICEN), FAC CIENCIAS SOCIALES; Publ
投票 SCIE期刊THERAPEUTIC DRUG MONITORING 2024/2025影响因子:2.885 (THER DRUG MONIT) (0163-4356). (PHARMACOLOGY & PHARMACY)(药理学与药学)S  ...234
Total Citations:4503; 2023 JIF:2.885; JIFRank: 158/354 ; Rank-JIF: 158; Number-of-JIF:354; 5 Year JIF:3.164; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.6; Immediacy Index:0.9; Immediacy Index-dealt:0.924; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:82; JCI Quartile:Q2; JCI Percentile:61.72; Eigenfactor:0.003; Normalized Eigenfactor:0.67; Article Influence Score:0.77; JIF Percentile:55.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:105; % of Articles in Citable items:0.781; Cited Half-Life:9.7; Citing Half-Life:8.5; % of OA Gold:0.1474; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBR
投票 SCIE期刊JOURNAL OF ONCOLOGY PHARMACY PRACTICE 2024/2025影响因子:1.147 (J ONCOL PHARM PRACT) (1078-1552). (PHARMACOLOGY & PHAR  ...234
Total Citations:2396; 2023 JIF:1.147; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.262; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.9; Immediacy Index:0.2; Immediacy Index-dealt:0.287; 2023 JCI:0.25; JCI Rank: 303/354 ; Total Articles:210; JCI Quartile:Q4; JCI Percentile:14.55; Eigenfactor:0.003; Normalized Eigenfactor:0.753; Article Influence Score:0.288; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:239; % of Articles in Citable items:0.8787; Cited Half-Life:3.9; Citing Half-Life:6.8; % of OA Gold:0.0645; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLAND
投票 SCIE期刊CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 2024/2025影响因子:2.496 (CANCER BIOTHER RADIO) (1084-9785). (PHARMACOLOGY  ...234
Total Citations:2492; 2023 JIF:2.496; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.635; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.4; Immediacy Index:0.7; Immediacy Index-dealt:0.784; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:25; JCI Quartile:Q2; JCI Percentile:60.4; Eigenfactor:0.002; Normalized Eigenfactor:0.446; Article Influence Score:0.481; JIF Percentile:40.2; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:27; % of Articles in Citable items:0.9259; Cited Half-Life:5; Citing Half-Life:6; % of OA Gold:0.0517; Publisher name:WILEY-V C H VERLAG GMBH; Publisher address:POSTFACH 101161, WEINHEIM, GERMANY, 6
投票 SCIE期刊Microbial Drug Resistance 2024/2025影响因子:2.373 (MICROB DRUG RESIST) (1076-6294). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:4092; 2023 JIF:2.373; JIFRank: 199/354 ; Rank-JIF: 199; Number-of-JIF:354; 5 Year JIF:3.593; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.2; Immediacy Index:0.4; Immediacy Index-dealt:0.412; 2023 JCI:0.57; JCI Rank: 210/354 ; Total Articles:62; JCI Quartile:Q3; JCI Percentile:44.41; Eigenfactor:0.004; Normalized Eigenfactor:0.884; Article Influence Score:0.73; JIF Percentile:32.6; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:64; % of Articles in Citable items:0.9688; Cited Half-Life:5.5; Citing Half-Life:7.6; % of OA Gold:0.0567; Publisher name:IOS PRESS; Publisher address:NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013
投票 SCIE期刊INDIAN JOURNAL OF PHARMACOLOGY 2024/2025影响因子:1.492 (INDIAN J PHARMACOL) (0253-7613). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:2486; 2023 JIF:1.492; JIFRank: 275/354 ; Rank-JIF: 275; Number-of-JIF:354; 5 Year JIF:1.706; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.4; Immediacy Index:0.1; Immediacy Index-dealt:0.123; 2023 JCI:0.38; JCI Rank: 276/354 ; Total Articles:53; JCI Quartile:Q4; JCI Percentile:22.18; Eigenfactor:0.001; Normalized Eigenfactor:0.15; Article Influence Score:0.309; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:60; % of Articles in Citable items:0.8833; Cited Half-Life:10.4; Citing Half-Life:8.7; % of OA Gold:0; Publisher name:ST CYRIL AND ST METHODIUS UNIVERSITY PUBLISHING HOUSE; Publisher address:2 Theod
投票 SCIE期刊CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY 2024/2025影响因子:2.479 (CLIN EXP PHARMACOL P) (0305-1870). (PH  ...234
Total Citations:6151; 2023 JIF:2.479; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.474; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.3; Immediacy Index:0.7; Immediacy Index-dealt:0.772; 2023 JCI:0.75; JCI Rank: 144/354 ; Total Articles:66; JCI Quartile:Q3; JCI Percentile:47.65; Eigenfactor:0.003; Normalized Eigenfactor:0.649; Article Influence Score:0.462; JIF Percentile:51.2; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:73; % of Articles in Citable items:0.9041; Cited Half-Life:10.5; Citing Half-Life:6; % of OA Gold:0.0767; Publisher name:SPRINGERNATURE; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9
投票 SCIE期刊ANTI-CANCER DRUGS 2024/2025影响因子:1.874 (ANTI-CANCER DRUG) (0959-4973). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Ci  ...234
Total Citations:4075; 2023 JIF:1.874; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.911; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.7; Immediacy Index-dealt:0.768; 2023 JCI:0.63; JCI Rank: 190/354 ; Total Articles:123; JCI Quartile:Q3; JCI Percentile:46.47; Eigenfactor:0.002; Normalized Eigenfactor:0.524; Article Influence Score:0.365; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:142; % of Articles in Citable items:0.8662; Cited Half-Life:8.4; Citing Half-Life:5.7; % of OA Gold:0.1889; Publisher name:MINERALOGICAL SOC AMER; Publisher address:3635 CONCORDE PKWY STE 500, CHA
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 10:25
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块